V. L. Tunitskaya

807 total citations
47 papers, 530 citations indexed

About

V. L. Tunitskaya is a scholar working on Molecular Biology, Hepatology and Infectious Diseases. According to data from OpenAlex, V. L. Tunitskaya has authored 47 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 16 papers in Hepatology and 10 papers in Infectious Diseases. Recurrent topics in V. L. Tunitskaya's work include Hepatitis C virus research (16 papers), RNA and protein synthesis mechanisms (12 papers) and DNA and Nucleic Acid Chemistry (11 papers). V. L. Tunitskaya is often cited by papers focused on Hepatitis C virus research (16 papers), RNA and protein synthesis mechanisms (12 papers) and DNA and Nucleic Acid Chemistry (11 papers). V. L. Tunitskaya collaborates with scholars based in Russia, Belgium and Finland. V. L. Tunitskaya's co-authors include Sergey N. Kochetkov, Alexander V. Ivanov, Olga A. Smirnova, Marina K. Kukhanova, B. K. Chernov, Maria Isaguliants, Alex R. Khomutov, Dmitry L. Lyakhov, Tuomo A. Keinänen and Leena Alhonen and has published in prestigious journals such as Scientific Reports, FEBS Letters and International Journal of Molecular Sciences.

In The Last Decade

V. L. Tunitskaya

46 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. L. Tunitskaya Russia 14 393 86 82 79 72 47 530
Tammy K. Antonucci United States 11 300 0.8× 30 0.3× 130 1.6× 88 1.1× 155 2.2× 20 572
Tatiana Tolstykh United States 8 216 0.5× 25 0.3× 132 1.6× 162 2.1× 85 1.2× 10 448
G. Renuka Kumar United States 16 394 1.0× 23 0.3× 146 1.8× 165 2.1× 48 0.7× 22 771
Chuanling Zhang China 17 435 1.1× 32 0.4× 95 1.2× 128 1.6× 146 2.0× 26 691
Lucid Belmudes France 12 240 0.6× 70 0.8× 165 2.0× 30 0.4× 16 0.2× 27 557
J.M. Caruthers United States 9 918 2.3× 70 0.8× 40 0.5× 42 0.5× 157 2.2× 10 1.1k
Cheryl L. Quinn United States 10 376 1.0× 36 0.4× 47 0.6× 42 0.5× 89 1.2× 14 499
Suthathip Kittisenachai Thailand 12 164 0.4× 41 0.5× 48 0.6× 133 1.7× 25 0.3× 32 518
Limei Yang China 12 238 0.6× 61 0.7× 27 0.3× 59 0.7× 20 0.3× 23 460
Juili Lin-Goerke United States 10 188 0.5× 20 0.2× 61 0.7× 83 1.1× 43 0.6× 11 506

Countries citing papers authored by V. L. Tunitskaya

Since Specialization
Citations

This map shows the geographic impact of V. L. Tunitskaya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. L. Tunitskaya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. L. Tunitskaya more than expected).

Fields of papers citing papers by V. L. Tunitskaya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. L. Tunitskaya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. L. Tunitskaya. The network helps show where V. L. Tunitskaya may publish in the future.

Co-authorship network of co-authors of V. L. Tunitskaya

This figure shows the co-authorship network connecting the top 25 collaborators of V. L. Tunitskaya. A scholar is included among the top collaborators of V. L. Tunitskaya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. L. Tunitskaya. V. L. Tunitskaya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Хомутов, М. А., Vladimir A. Mitkevich, V. L. Tunitskaya, et al.. (2023). C-Methylated Spermidine Derivatives: Convenient Syntheses and Antizyme-Related Effects. Biomolecules. 13(6). 916–916.
2.
Kukhanova, Marina K., V. L. Tunitskaya, Olga A. Smirnova, et al.. (2019). Hepatitis C Virus RNA-Dependent RNA Polymerase Is Regulated by Cysteine S-Glutathionylation. Oxidative Medicine and Cellular Longevity. 2019. 1–11. 8 indexed citations
3.
Smirnova, Olga A., Olga N. Ivanova, V. L. Tunitskaya, et al.. (2016). Analysis of the Domains of Hepatitis C Virus Core and NS5A Proteins that Activate the Nrf2/ARE Cascade. Acta Naturae. 8(3). 123–127. 12 indexed citations
4.
Magrì, Andrea, А. А. Озеров, V. L. Tunitskaya, et al.. (2016). Exploration of acetanilide derivatives of 1-(ω-phenoxyalkyl)uracils as novel inhibitors of Hepatitis C Virus replication. Scientific Reports. 6(1). 29487–29487. 13 indexed citations
5.
Tunitskaya, V. L., et al.. (2012). Biogenic polyamines spermine and spermidine activate RNA polymerase and inhibit RNA helicase of hepatitis C virus. Biochemistry (Moscow). 77(10). 1172–1180. 17 indexed citations
6.
Tunitskaya, V. L., А. А. Иванов, Alexander V. Ivanov, et al.. (2011). Inhibition of the helicase activity of the HCV NS3 protein by symmetrical dimeric bis-benzimidazoles. Bioorganic & Medicinal Chemistry Letters. 21(18). 5331–5335. 17 indexed citations
7.
Tunitskaya, V. L., et al.. (2008). Hepatitis C virus helicase/NTPase: an efficient expression system and new inhibitors. Biochemistry (Moscow). 73(6). 660–668. 9 indexed citations
8.
Starodubova, Elizaveta, Andreas Boberg, А. В. Морозов, et al.. (2008). HIV-1 reverse transcriptase artificially targeted for proteasomal degradation induces a mixed Th1/Th2-type immune response. Vaccine. 26(40). 5170–5176. 15 indexed citations
9.
Ivanov, Alexander V., et al.. (2006). Development of the system ensuring a high-level expression of hepatitis C virus nonstructural NS5B and NS5A proteins. Protein Expression and Purification. 48(1). 14–23. 46 indexed citations
10.
Козлов, М. В., et al.. (2006). Hepatitis C virus RNA-dependent RNA polymerase: Study on the inhibition mechanism by pyrogallol derivatives. Biochemistry (Moscow). 71(9). 1021–1026. 5 indexed citations
11.
Ermolinsky, Boris S., V. L. Tunitskaya, Arthur Van Aerschot, et al.. (2004). Interaction of HIV-1 Reverse Transcriptase with Modified Oligonucleotide Primers Containing 2′-O-β-D-Ribofuranosyladenosine. Biochemistry (Moscow). 69(2). 130–136. 1 indexed citations
12.
Tunitskaya, V. L. & Sergey N. Kochetkov. (2002). Structural–Functional Analysis of Bacteriophage T7 RNA Polymerase. Biochemistry (Moscow). 67(10). 1124–1135. 42 indexed citations
13.
Kochetkov, Sergey N., et al.. (1998). Recent studies of T7 RNA polymerase mechanism. FEBS Letters. 440(3). 264–267. 33 indexed citations
14.
Ermolinsky, Boris S., V. L. Tunitskaya, Sergey N. Mikhailov, et al.. (1998). Disaccharide Nucleosides And Their Enzymatic And Chemical Incorporation Into Oligonucleotides. Nucleosides and Nucleotides. 17(9-11). 1681–1684. 6 indexed citations
15.
Tunitskaya, V. L., et al.. (1997). Substrate properties of C′‐methyl UTP derivatives in T7 RNA polymerase reactions. Evidence for N‐type NTP conformation. FEBS Letters. 400(3). 263–266. 3 indexed citations
16.
Chernov, B. K., et al.. (1995). Targeted mutagenesis identifies Asp-569 as a catalytically critical residue in T7 RNA polymerase. Molecular and General Genetics MGG. 247(1). 110–113. 7 indexed citations
17.
Tunitskaya, V. L., et al.. (1994). Functional studies of bacteriophage T7 RNA polymerase point mutants containing amino acid substitutions in the motif B of the enzyme active site. Biochemistry (Moscow). 59(4). 494–502. 2 indexed citations
18.
Tunitskaya, V. L., et al.. (1993). Tyr‐571 is involved in the T7 RNA polymerase binding to its promoter. FEBS Letters. 320(1). 9–12. 4 indexed citations
19.
Tunitskaya, V. L., et al.. (1992). On the functional role of the Tyr‐639 residue of bacteriophage T7 RNA polymerase. FEBS Letters. 306(2-3). 129–132. 7 indexed citations
20.
Zaychikov, Evgeny, et al.. (1991). Lys631 residue in the active site of the bacteriophage T7 RNA polymerase. European Journal of Biochemistry. 195(3). 841–847. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tammy K. Antonucci Breakdown of academic impact, for papers by Tatiana Tolstykh Breakdown of academic impact, for papers by G. Renuka Kumar Breakdown of academic impact, for papers by Chuanling Zhang Breakdown of academic impact, for papers by Lucid Belmudes Breakdown of academic impact, for papers by J.M. Caruthers Breakdown of academic impact, for papers by Cheryl L. Quinn Breakdown of academic impact, for papers by Suthathip Kittisenachai Breakdown of academic impact, for papers by Limei Yang Breakdown of academic impact, for papers by Juili Lin-Goerke
Rankless by CCL
2026